Experimental Ebola vaccine OK’d for pregnant women

Health officials on Feb. 20 ruled that women who are pregnant or lactating may now receive Merck’s experimental Ebola vaccine in the Democratic Republic of Congo, reports STAT.

Advertisement

Three things to know:

1. A committee advising the Congolese Ministry of Health made the decision with support from the World Health Organization. The rule change also allows children under age 1 to receive the experimental vaccine.

2. The decision marks the reversal of a controversial policy that excluded pregnant women from receiving the vaccine due to safety concerns. The original policy was met with large opposition from public health experts.

3. As of Feb. 20, Congo health officials have reported 844 confirmed and probable Ebola infections linked to the country’s ongoing outbreak. Health workers have also administered more than 80,000 experimental Ebola vaccines to people in the Congo and nearby countries since August.

More articles on clinical leadership and infection control:
6 factors linked to hospital-onset sepsis
Maryland hospitals reduce infections, readmission rates
CDC: US measles cases already surpass 2016, 2017 totals

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.